ArticleScience translational medicine2022

Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.

Shane J F Cronin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.